Literature DB >> 24432870

Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1/2 kinase inhibitors.

Steven T Staben1, Jianwen A Feng, Karen Lyle, Marcia Belvin, Jason Boggs, Jason D Burch, Ching-ching Chua, Haifeng Cui, Antonio G DiPasquale, Lori S Friedman, Christopher Heise, Hartmut Koeppen, Adrian Kotey, Robert Mintzer, Angela Oh, David Allen Roberts, Lionel Rouge, Joachim Rudolph, Christine Tam, Weiru Wang, Yisong Xiao, Amy Young, Yamin Zhang, Klaus P Hoeflich.   

Abstract

Structure-based methods were used to design a potent and highly selective group II p21-activated kinase (PAK) inhibitor with a novel binding mode, compound 17. Hydrophobic interactions within a lipophilic pocket past the methionine gatekeeper of group II PAKs approached by these type I 1/2 binders were found to be important for improving potency. A structure-based hypothesis and strategy for achieving selectivity over group I PAKs, and the broad kinome, based on unique flexibility of this lipophilic pocket, is presented. A concentration-dependent decrease in tumor cell migration and invasion in two triple-negative breast cancer cell lines was observed with compound 17.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24432870     DOI: 10.1021/jm401768t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

Review 1.  Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.

Authors:  Byung Hak Ha; Elizabeth M Morse; Benjamin E Turk; Titus J Boggon
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

Review 2.  P21 activated kinases: structure, regulation, and functions.

Authors:  Chetan K Rane; Audrey Minden
Journal:  Small GTPases       Date:  2014-03-21

Review 3.  Targeting cancer with kinase inhibitors.

Authors:  Stefan Gross; Rami Rahal; Nicolas Stransky; Christoph Lengauer; Klaus P Hoeflich
Journal:  J Clin Invest       Date:  2015-05-01       Impact factor: 14.808

4.  Targeting Dynamic ATP-Binding Site Features Allows Discrimination between Highly Homologous Protein Kinases.

Authors:  Sujata Chakraborty; Takayuki Inukai; Linglan Fang; Martin Golkowski; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

5.  Leveraging the Pre-DFG Residue Thr-406 To Obtain High Kinase Selectivity in an Aminopyrazole-Type PAK1 Inhibitor Series.

Authors:  Joachim Rudolph; Ignacio Aliagas; James J Crawford; Simon Mathieu; Wendy Lee; Qi Chao; Ping Dong; Lionel Rouge; Weiru Wang; Christopher Heise; Lesley J Murray; Hank La; Yanzhou Liu; Gerard Manning; François Diederich; Klaus P Hoeflich
Journal:  ACS Med Chem Lett       Date:  2015-05-20       Impact factor: 4.345

6.  Identifying three-dimensional structures of autophosphorylation complexes in crystals of protein kinases.

Authors:  Qifang Xu; Kimberly L Malecka; Lauren Fink; E Joseph Jordan; Erin Duffy; Samuel Kolander; Jeffrey R Peterson; Roland L Dunbrack
Journal:  Sci Signal       Date:  2015-12-01       Impact factor: 8.192

7.  Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor.

Authors:  Alexei S Karpov; Payman Amiri; Cornelia Bellamacina; Marie-Helene Bellance; Werner Breitenstein; Dylan Daniel; Regis Denay; Doriano Fabbro; Cesar Fernandez; Inga Galuba; Stephanie Guerro-Lagasse; Sascha Gutmann; Linda Hinh; Wolfgang Jahnke; Julia Klopp; Albert Lai; Mika K Lindvall; Sylvia Ma; Henrik Möbitz; Sabina Pecchi; Gabriele Rummel; Kevin Shoemaker; Joerg Trappe; Charles Voliva; Sandra W Cowan-Jacob; Andreas L Marzinzik
Journal:  ACS Med Chem Lett       Date:  2015-05-22       Impact factor: 4.345

8.  Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells.

Authors:  Peilu Song; Fan Zhao; Dahong Li; Jiqiang Qu; Miao Yao; Yuan Su; Hanxun Wang; Miaomiao Zhou; Yujie Wang; Yinli Gao; Feng Li; Dongmei Zhao; Fengjiao Zhang; Yu Rao; Mingyu Xia; Haitao Li; Jian Wang; Maosheng Cheng
Journal:  Acta Pharm Sin B       Date:  2022-03-04       Impact factor: 14.903

9.  PAK4 crystal structures suggest unusual kinase conformational movements.

Authors:  Eric Y Zhang; Byung Hak Ha; Titus J Boggon
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-10-07       Impact factor: 3.036

10.  An in cellulo-derived structure of PAK4 in complex with its inhibitor Inka1.

Authors:  Yohendran Baskaran; Khay C Ang; Praju V Anekal; Wee L Chan; Jonathan M Grimes; Ed Manser; Robert C Robinson
Journal:  Nat Commun       Date:  2015-11-26       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.